Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous Immunofluorescence-Based In Situ mRNA Expression and Protein Detection in Bone Marrow Biopsy Samples.

Bio-protocol·2026
Same author

Robust causal gene network estimation for large-scale single-cell perturbation screens using reduced control function.

bioRxiv : the preprint server for biology·2026
Same author

Development of an automated, imaging-based preoperative screening model for early identification of malnutrition in an abdominal surgery cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Factors Associated with Adherence to Recommended Colorectal Surveillance Intervals in Lynch Syndrome.

Cancers·2026
Same author

Rejoinder to the discussion on "INTACT: A method for integration of longitudinal physical activity data from multiple sources".

Biometrics·2026
Same author

INTACT: a method for integration of longitudinal physical activity data from multiple sources.

Biometrics·2026

Related Experiment Video

Updated: Jul 2, 2026

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

U-statistics-based tests for multiple genes in genetic association studies.

Zhi Wei1, Mingyao Li, Timothy Rebbeck

  • 1Department of Computer Science, New Jersey Institute of Technology, University Heights, Newark, NJ 07102, USA.

Annals of Human Genetics
|August 12, 2008
PubMed
Summary
This summary is machine-generated.

New statistical methods enhance pathway-based genetic association studies by analyzing multiple gene variants simultaneously. These data-adaptive U-statistics improve power for complex traits, especially with multiple small-effect genetic loci.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • Biological pathway understanding is crucial for genetic and molecular epidemiology.
  • Pathway-based studies analyze gene variants within specific biological pathways.
  • Complex traits often involve multiple genetic loci and alleles, necessitating advanced analytical approaches.

Purpose of the Study:

  • To develop novel nonparametric test statistics for pathway-based genetic association studies.
  • To create methods capable of simultaneously assessing the effects of multiple genetic markers.
  • To offer robust statistical tools for both qualitative (case-control) and quantitative (continuous phenotype) data.

Main Methods:

  • Development of two nonparametric test statistics utilizing data-adaptive U-statistics.
  • Application of methods to handle both dichotomous and continuous phenotypic data.
  • Simulation studies to evaluate the performance and power of the proposed methods compared to existing techniques.

Main Results:

  • The proposed data-adaptive U-statistic methods demonstrate superior power over standard approaches, particularly for complex traits influenced by multiple risk loci with small genetic effects.
  • When few disease-predisposing genes are involved, the new methods achieve power comparable to single-marker tests.
  • The methods were successfully applied to a breast cancer and hormone metabolism pathway candidate gene association study.

Conclusions:

  • The developed nonparametric tests provide a powerful and flexible approach for pathway-based genetic association studies.
  • These methods can effectively capture the complex genetic architecture of common diseases.
  • Potential applications extend to genome-wide association studies, offering enhanced discovery capabilities.